Accueil

Dernières infos des projets sur les cellules souches financés par l'UE

Où va votre argent? Ces brefs résumés des activités des projets de recherche sur les cellules financés par l'UE ont pour but d'informer les citoyens européens sur les progrès aux financements public dans le domaine. Ils sont basés sur les rapports à la Commission européenne par les projets.

Using stem cells to develop new therapies for Parkinson’s and Huntington’s Diseases

Publié: 
24 Oct 2011
This summary covers: 
Déc 2008 - Juil 2011

About NeuroStemcell

NeuroStemcell brings stem cell biology and clinical science together to develop and test new approaches to stem-cell-based therapy. We study Parkinson’s (PD) and Huntington’s (HD) diseases, which are degenerative diseases of the brain. In each of these diseases, specific types of neurons (nerve cells) die: dopaminergic neurons in PD and striatal neurons in HD. Our main strategy is to produce neurons in the lab that, if our approaches are successful, may in future be transplanted into patients. To make these neurons, we start from all the available stem cell types (embryonic, fetal, adult, reprogrammed) and compare the ability of cells from these different sources to generate the desired neurons.

Pioneering stem cell science using biological and computational expertise

Publié: 
5 Oct 2011
This summary covers: 
Mar 2008 - Aoû 2010

About EuroSyStem

Combining biological and computational approachesCombining biological and computational approaches

EuroSyStem began by bringing together leading stem cell scientists from eight European countries. Their aim was to further understand stem cell science by combining both biological and computational techniques. Understanding how stem cells work means that their potential for treating disease can be fully realised in the future. EuroSyStem has made significant progress in each of its scientific areas. It has also established a network of stem cell scientists, now spanning 17 countries and 61 research groups, and has provided quality training and collaborative research opportunities.

Progressing towards the clinic with skeletal muscle and epithelial stem cells

Publié: 
1 Juil 2011
This summary covers: 
Mar 2009 - Fév 2011

Muscle fibres labelled greenMuscle fibres labelled green

About OptiStem

OptiStem brings stem cell biology and clinical science together in a drive to develop and test new stem-cell-based approaches to therapy. We are focussed on degenerative diseases of the skeletal muscle, and repair of diseased or damaged epithelial tissues such as the skin or cornea. In the first two years of the project we have made significant progress in all three strands of our work – basic science, pre-clinical research and our planned clinical trials.

 

 

Building the foundations for human embryonic stem cell research

Publié: 
14 Déc 2010
This summary covers: 
Aoû 2006 - Juil 2010

About ESTOOLS

The ESTOOLS project aimed to develop the tools and knowledge required for application of human embryonic stem (ES) cells in industry and medicine. It was the largest consortium of researchers studying human ES cells in Europe. The project teamed up 21 research groups, bringing together more than 150 scientists in 10 countries. It was the first EU-funded project focused entirely on human embryonic stem cells.